Endeavour Invest (investor - Others)

See something wrong or missing? Let us know
Offices:Copenhagen

Endeavour Invest is an investment vehicle controlled by Anders Østergaard in Denmark

Average round investment:1.46M USD
Average number per year:1.0
Distribution: 2024 (1)
Portfolio companies: Denmark Cell2Cure
Mostly invests in: Denmark Denmark (1) Biotech (1)

1 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Endeavour Invest

Name Criteria
United States Rhia Ventures
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Swiss Invest Group
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Denmark Klaus Edvardsen
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Denmark UCPH Ventures
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Sanner Ventures
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Denmark Christian Leroy
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Denmark Ludvig Find
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Andreas Ehn
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden Axilium Capital
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden Enexis AB
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Top